2TP-25475-40105 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-02
Dose 1 — Pfizer-BioNTech
2021-02-23
Dose 2 — Pfizer-BioNTech
2021-03-01
Registered in v-safe
2021-03-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-02
Health check-in — day 7, dose 2
Feeling: Poor · Fever · Headache, Fatigue or tiredness

Adult check-in
2021-03-09
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-03-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-25
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-30
Survey response — day 35, dose 2
MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities

Free text: Headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-30
Report sent to call center — day 35, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-04-09
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-27
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-24
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-02	Pfizer-BioNTech
2	2021-02-23	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-03-30	priority 2/3

Free text

Release 6 — day 35, dose 2

2021-03-30

Symptoms: Headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release